Dong Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dong Guo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Jianfeng Gong
Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
1 shared publication - Jieshou Li
Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
1 shared publication - Lili Gu
Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
1 shared publication - Ning Li
Department of Colorectal Disease, Intestinal Microenvironment Treatment Center, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
1 shared publication - Weiming Zhu
Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
1 shared publication - Yao Wei
Department of Intensive Care Unit, The First Affiliated Hospital of Soochow University, Suzhou, China
1 shared publication
Latest Publications
- Open Access
- 11 July 2015
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 15 (1) , 1-8
Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis
Nosocomial Methicillin-resistant Staphylococcus aureus (MRSA) enteritis is rare but can be fatal unless it is detected at an early stage and treated effectively. Dysbiosis of the gut is one of the leading reasons of MRSA enteritis. Fecal microbiota transplantation (FMT) is a burgeoning treatment to rectify this imbalance. But the impact of FMT on MRSA enterocoitis is still unknown yet. A total of 5 patients diagnosed as MRSA enteritis during the early postoperative period were given vancomycin 2 g/day for 3 days and FMT for three continuous days as a standard treatment. There was a 100 % clinical response rate that all the symptoms resulting from MRSA enterocolitis disappeared and MRSA in the feces eliminated clearly. The microbiota profile in feces of the patients also regained balance. FMT can be a preferential measure to restore the dysbiosis caused by MSRA enterocolitis.
- 11 July 2015
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 15 (1) , 1-8
Open AccessFecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis
Nosocomial Methicillin-resistant Staphylococcus aureus (MRSA) enteritis is rare but can be fatal unless it is detected at an early stage and treated effectively. Dysbiosis of the gut is one of the leading reasons of MRSA enteritis. Fecal microbiota transplantation (FMT) is a burgeoning treatment to rectify this imbalance. But the impact of FMT on MRSA enterocoitis is still unknown yet. A total of 5 patients diagnosed as MRSA enteritis during the early postoperative period were given vancomycin 2 g/day for 3 days and FMT for three continuous days as a standard treatment. There was a 100 % clinical response rate that all the symptoms resulting from MRSA enterocolitis disappeared and MRSA in the feces eliminated clearly. The microbiota profile in feces of the patients also regained balance. FMT can be a preferential measure to restore the dysbiosis caused by MSRA enterocolitis.